±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 173  |  »Ø¸´: 0
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

mkyye

¾èÖú¹ó±ö (ÖªÃû×÷¼Ò)

×öÈËÒª´óÆø£¬ÐÄÐØÒª¿í¹ã

[½»Á÷] Ò©ÎïÁÙ´²ÊÔÑé³£ÓÃÃû´ÊÊÍÒå

Ò©ÎïÁÙ´²ÊÔÑé³£ÓÃÃû´ÊÊÍÒå


Ãû´ÊÊÍÒå

1£®ÁÙ´²ÊÔÑ飨Clinical Trial£©£ºÖ¸ÈκÎÔÚÈËÌ壨²¡ÈË»ò½¡¿µÖ¾Ô¸ÕßÉíÉÏ£©½øÐÐÒ©Æ·µÄϵͳÐÔÑо¿£¬ÒÔ֤ʵ»ò½ÒʾÑо¿Ò©Æ·µÄ×÷Óᢲ»Á¼·´Ó¦¼°£¯»òÊÔÑéÓÃÒ©Æ·µÄÎüÊÕ¡¢·Ö²¼¡¢´úлºÍÅÅй£¬Ä¿µÄÊÇÈ·¶¨Ñо¿Ò©Æ·µÄÁÆÐ§Ó밲ȫÐÔ¡£

2£®ÊÔÑé·½°¸£¨Protoco1£©£ºÐðÊöÊÔÑéµÄ±³¾°¡¢ÀíÂÛ»ù´¡ºÍÄ¿µÄ£¬ÊÔÑéÉè¼Æ¡¢·½·¨ºÍ×éÖ¯£¬°üÀ¨Í³¼ÆÑ§¿¼ÂÇ¡¢ÊÔÑéÖ´ÐкÍÍê³ÉµÄÌõ¼þ¡£·½°¸±ØÐëÓɲμÓÊÔÑéµÄÖ÷ÒªÑо¿Õß¡¢Ñо¿»ú¹¹ºÍÉê°ìÕßǩղ¢×¢Ã÷ÈÕÆÚ¡£

3.Ñо¿ÕßÊֲᣨInvestigator's Brochure£©£ºÊÇÓйØÊÔÑéÓÃÒ©Æ·ÔÚ½øÐÐÈËÌåÑо¿Ê±ÒÑÓеÄÁÙ´²Óë·ÇÁÙ´²×ÊÁÏ¡£

4£®ÖªÇéͬÒ⣨Informed Consent£©£ºÖ¸ÏòÊÜÊÔÕ߸æÖªÒ»ÏîÊÔÑéµÄ¸÷¸ö·½ÃæÇé¿öºó£¬ÊÜÊÔÕß×ÔԸȷÈÏÆäͬÒâ²Î¼Ó¸ÃÏîÁÙ´²ÊÔÑéµÄ¹ý³Ì£¬ÐëÒÔÇ©ÃûºÍ×¢Ã÷ÈÕÆÚµÄÖªÇéͬÒâÊé×÷ΪÎļþÖ¤Ã÷¡£

5£®ÖªÇéͬÒâÊ飨Informed Consent form£©£ºÊÇÿλÊÜÊÔÕß±íʾ×ÔÔ¸²Î¼ÓijһÊÔÑéµÄÎļþÖ¤Ã÷¡£Ñо¿Õß±ØÐëÏòÊÜÊÔÕß˵Ã÷ÊÔÑéÐÔÖÊ¡¢ÊÔÑéÄ¿µÄ¡¢¿ÉÄܵÄÊÜÒæºÍΣÏÕ¡¢¿É¹©Ñ¡ÓÃµÄÆäËûÖÎÁÆ·½·¨ÒÔ¼°·ûºÏ¡¶ºÕ¶ûÐÁ»ùÐûÑÔ¡·¹æ¶¨µÄÊÜÊÔÕßµÄȨÀûºÍÒåÎñµÈ£¬Ê¹ÊÜÊÔÕß³ä·ÖÁ˽âºó±í´ïÆäͬÒâ¡£

6£®Â×ÀíίԱ»á£¨Ethics Committee£©£ºÓÉҽѧרҵÈËÔ±¡¢·¨ÂÉר¼Ò¼°·ÇÒ½ÎñÈËÔ±×é³ÉµÄ¶ÀÁ¢×éÖ¯£¬ÆäÖ°ÔðΪºË²éÁÙ´²ÊÔÑé·½°¸¼°¸½¼þÊÇ·ñºÏºõµÀµÂ£¬²¢ÎªÖ®Ìṩ¹«ÖÚ±£Ö¤£¬È·±£ÊÜÊÔÕߵݲȫ¡¢½¡¿µºÍÈ¨ÒæÊܵ½±£»¤¡£¸ÃίԱ»áµÄ×é³ÉºÍÒ»Çл²»Ó¦ÊÜÁÙ´²ÊÔÑé×éÖ¯ºÍʵʩÕߵĸÉÈÅ»òÓ°Ïì¡£

7£®Ñо¿Õߣ¨Investigator)£ºÊµÊ©ÁÙ´²ÊÔÑé²¢¶ÔÁÙ´²ÊÔÑéµÄÖÊÁ¿ºÍÊÜÊÔÕߵݲȫºÍÈ¨ÒæµÄ¸ºÔðÕß¡£Ñо¿Õß±ØÐë¾­¹ý×ʸñÉó²é£¬¾ßÓÐÁÙ´²ÊÔÑéµÄ×¨ÒµÌØ³¤¡¢×ʸñºÍÄÜÁ¦¡£ÔÚ¶àÖÐÐÄÁÙ´²ÊÔÑéÖУ¬ÓÉÒ»ÃûÖ÷ÒªÑо¿Õß¶ÔÁÙ´²ÊÔÑéʵʩ×ܸºÔ𣬲¢×÷Ϊ¸÷ÊÔÑéÖÐÐļäµÄЭµ÷ÈË¡£

8£®Ð­µ÷Ñо¿Õߣ¨Coordinating Investigator)£ºÔÚ¶àÖÐÐÄÁÙ´²ÊÔÑéÖиºÔðЭµ÷¸÷²Î¼ÓÖÐÐĵÄÑо¿ÕߵŤ×÷µÄÒ»ÃûÑо¿Õß¡£

9.É걨Ö÷°ìÕߣ¨Sponsor£©£º¼ò³ÆÉê°ìÕߣ¬·¢ÆðÒ»ÏîÁÙ´²ÊÔÑ飬²¢¶Ô¸ÃÊÔÑéµÄÆô¶¯¡¢¹ÜÀí¡¢²ÆÎñºÍ¼àÊÓ¸ºÔðµÄ¹«Ë¾¡¢»ú¹¹»ò×éÖ¯¡£

10£®¼à²éÔ±£¨Monitor£©£ºÓÉÉê°ìÕßÈÎÃü²¢¶ÔÉê°ìÕ߸ºÔðµÄ¾ß±¸Ïà¹ØÖªÊ¶µÄÈËÔ±£¬ÆäÈÎÎñÊǼà²éºÍ±¨¸æÊÔÑéµÄ½øÐÐÇé¿öºÍºËʵÊý¾Ý¡£

l1£®»ü²é£¨Audit£©£ºÖ¸Óɲ»Éæ¼°ÊÔÑéµÄÈËÔ±Ëù½øÐеÄÒ»ÖÖϵͳÐÔ¼ì²é£¬ÒÔÅж¨ÊÔÑéµÄʵʩ¡¢Êý¾ÝµÄ¼Ç¼ºÍ·ÖÎöÊÇ·ñÓëÊÔÑé·½°¸¡¢Ò©Æ·ÁÙ´²ÊÔÑé¹ÜÀí¹æ·¶¼°·¨¹æÒªÇóÏà·û¡£

12£®ÊӲ죨Inspection£©£ºÒ©Æ·¼à¶½¹ÜÀí²¿ÃŶÔÓйØÒ»ÏîÁÙ´²ÊÔÑéµÄÎļþ¡¢ÉèÊ©¡¢¼Ç¼ºÍÆäËû·½Ãæ½øÐйٷ½ÉóÔÄ£¬ÊÓ²ì¿ÉÒÔÔÚÊÔÑ鵥λ¡¢Éê°ìÕßËùÔڵػòºÏͬÑо¿×éÖ¯ËùÔڵؽøÐС£

13£®²¡Àý±¨¸æ±í£¨Case Report form, CRF£©£ºÖ¸°´ÊÔÑé·½°¸Ëù¹æ¶¨Éè¼ÆµÄÒ»ÖÖÎļþ£¬ÓÃÒԼǼÿһÃûÊÜÊÔÕßÔÚÊÔÑé¹ý³ÌÖеÄÊý¾Ý¡£

14£®×ܽᱨ¸æ£¨Final Report£©£ºÊÔÑéÍê³ÉºóµÄÒ»·ÝÏ꾡×ܽᣬ°üÀ¨ÊÔÑé·½·¨Óë²ÄÁÏ¡¢½á¹ûµÄÃèÊöÓëÆÀ¹À¡¢Í³¼Æ·ÖÎöÒÔ¼°×îÖÕËù»ñ¼ø¶¨ÐԵġ¢ºÏºõµÀµÂµÄͳ¼ÆÑ§ºÍÁÙ´²ÆÀ¼Û±¨¸æ¡£

15.Ò©Æ·£¨Pharmaceutical Product£©£ºÖ¸ÓÃÓÚÔ¤·À¡¢ÖÎÁÆ¡¢Õï¶ÏÈ˵ļ²²¡£¬ÓÐÄ¿µÄµØµ÷½ÚÈ˵ÄÉúÀí»úÄܲ¢¹æ¶¨ÓÐÊÊÓ¦Ö¤¡¢Ó÷¨ºÍÓÃÁ¿µÄÎïÖÊ¡£

16£®ÊÔÑéÓÃÒ©Æ·£¨Investigational Product£©£ºÁÙ´²ÊÔÑéÖÐÓÃ×÷ÊÔÑé»ò²Î±ÈµÄÈκÎÒ©Æ·»ò°²Î¿¼Á¡£

17£®Ò©Æ·²»Á¼·´Ó¦£¨Adverse Drug Reaction£©£ºÔÚ°´¹æ¶¨¼ÁÁ¿Õý³£Ó¦ÓÃÒ©Æ·µÄ¹ý³ÌÖвúÉúµÄÓꦶø·ÇËùÆÚÍûµÄ¡¢ÓëÒ©Æ·Ó¦ÓÃÓÐÒò¹û¹ØÏµµÄ·´Ó¦¡£ÔÚÒ»ÖÖÐÂÒ©»òÒ©Æ·µÄÐÂÓÃ;µÄÁÙ´²ÊÔÑéÖУ¬ÆäÖÎÁƼÁÁ¿ÉÐδȷ¶¨Ê±£¬ËùÓÐÓꦶø·ÇËùÆÚÍûµÄ¡¢ÓëÒ©Æ·Ó¦ÓÃÓÐÒò¹û¹ØÏµµÄ·´Ó¦£¬Ò²Ó¦ÊÓΪҩƷ²»Á¼·´Ó¦¡£

18£®²»Á¼Ê¼þ£¨Adverse Event£©£º²¡ÈË»òÁÙ´²ÊÔÑéÊÜÊÔÕß½ÓÊÜÒ»ÖÖÒ©Æ·ºó³öÏֵIJ»Á¼Ò½Ñ§Ê¼þ£¬µ«²¢²»Ò»¶¨ÓëÖÎÁÆÓÐÒò¹û¹ØÏµ¡£

19£®ÑÏÖØ²»Á¼Ê¼þ£¨Serious Adverse Event£©£ºÁÙ´²ÊÔÑé¹ý³ÌÖз¢ÉúÐèסԺÖÎÁÆ¡¢ÑÓ³¤×¡ÔºÊ±¼ä¡¢É˲С¢Ó°Ï칤×÷ÄÜÁ¦¡¢Î£¼°ÉúÃü»òËÀÍö¡¢µ¼ÖÂÏÈÌì»ûÐεÈʼþ¡£

20£®±ê×¼²Ù×÷³ÌÐò£¨Standard Operating Procedure,SOP£©:ΪÓÐЧµØÊµÊ©ºÍÍê³ÉijһÁÙ´²ÊÔÑéÖÐÿÏ×÷ËùÄⶨµÄ±ê×¼¶øÏêϸµÄÊéÃæ¹æ³Ì¡£

21£®Éè䣨Blinding£¯Masking£©ÁÙ´²ÊÔÑéÖÐʹһ·½»ò¶à·½²»ÖªµÀÊÜÊÔÕßÖÎÁÆ·ÖÅäµÄ³ÌÐò¡£µ¥Ã¤Ö¸ÊÜÊÔÕß²»Öª£¬Ë«Ã¤Ö¸ÊÜÊÔÕß¡¢Ñо¿Õß¡¢¼à²éÔ±»òÊý¾Ý·ÖÎöÕß¾ù²»ÖªÖÎÁÆ·ÖÅä¡£

22£®ÖÊÁ¿¿ØÖÆ(Quality Control)£ºÓÃÒÔ±£Ö¤ÓëÁÙ´²ÊÔÑéÏà¹Ø»î¶¯µÄÖÊÁ¿´ïµ½ÒªÇóµÄ²Ù×÷ÐÔ¼¼ÊõºÍ³ÌÐò¡£

23£®ºÏͬÑо¿×éÖ¯£¨Contract Research Organization, CRO£©£ºÒ»ÖÖѧÊõÐÔ»òÉÌÒµÐԵĿÆÑ§»ú¹¹¡£Éê°ìÕß¿ÉίÍÐÆäÖ´ÐÐÁÙ´²ÊÔÑéÖеÄijЩ¹¤×÷ºÍÈÎÎñ£¬´ËÖÖίÍбØÐë×÷³öÊéÃæ¹æ¶¨¡£
»Ø¸´´ËÂ¥
Ð黳Èô¹È
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ mkyye µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005 +5 ioodiiij 2026-04-04 5/250 2026-04-05 08:16 by zhuwenxu
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤363ÇóÍÆ¼ö +5 zh096 2026-04-04 5/250 2026-04-05 08:07 by 544594351
[¿¼ÑÐ] 313Çóµ÷¼Á +3 º£ÈÕº£ÈÕ 2026-04-04 5/250 2026-04-05 07:54 by 544594351
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á +4 ÅãÁÕ¿´º£ 2026-04-04 4/200 2026-04-05 07:49 by 544594351
[¿¼ÑÐ] 306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +6 Àè°ÉÀ²À²ÄãºÜÓÐà 2026-04-03 6/300 2026-04-04 23:59 by ¹û¶³´óÍõ
[¿¼ÑÐ] 278Çóµ÷¼Á +14 ·¶æÃÄÈ 2026-04-04 15/750 2026-04-04 22:15 by lqwchd
[¿¼ÑÐ] 283Çóµ÷¼Á +4 mcbbc 2026-04-03 5/250 2026-04-04 20:51 by imissbao
[¿¼ÑÐ] 363Çóµ÷¼Á +7 zh096 2026-04-04 7/350 2026-04-04 17:13 by dongzh2009
[¿¼ÑÐ] »¯¹¤µ÷¼Á303·Ö£¬¹ýËļ¶ +28 ÆÜÎà´ý·ç 2026-04-02 28/1400 2026-04-03 21:40 by qlm5820
[¿¼ÑÐ] Çóµ÷¼Á +3 usbdndj 2026-04-03 3/150 2026-04-03 14:10 by dxiaoxin
[¿¼ÑÐ] 266Çóµ÷¼Á +3 08µçÆø¹¤³Ì 2026-04-03 3/150 2026-04-03 14:05 by 1753564080
[¿¼ÑÐ] ½¨»·£¬ÄÜÔ´£¬ÍÁľÀÏʦ·¹ý¿´Ò»¿´£¡£¡£¡ +5 ºÙºÙuu 2026-04-01 5/250 2026-04-03 11:47 by znian
[¿¼ÑÐ] 312Çóµ÷¼Á +4 ÉÞÔÂÉ« 2026-04-02 5/250 2026-04-03 08:21 by fangshan711
[¿¼ÑÐ] 293Çóµ÷¼Á +4 çæçæÀÖ 2026-04-02 4/200 2026-04-02 20:10 by 6781022
[¿¼ÑÐ] ÄÜÔ´¶¯Á¦ µ÷¼Á +3 ²»ÆÆ²»Á¢0 2026-04-02 3/150 2026-04-02 12:46 by ffffjjjj
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +9 Ë«ÂíβƦÀϰå2 2026-04-01 9/450 2026-04-02 12:14 by oooqiao
[¿¼ÑÐ] 337Çóµ÷¼Á +11 ¡¶Ê÷¡· 2026-03-29 11/550 2026-04-02 10:20 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] Ò»Ö¾Ô¸9³õÊÔ366 ±¾Ë«·ÇÇóµ÷¼Á +4 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 4/200 2026-04-02 09:56 by guanxin1001
[¿¼ÑÐ] ²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 hyl3153942 2026-03-29 10/500 2026-03-31 16:31 by hypershenger
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó320»¯Ñ§¹¤³ÌÓë¼¼Êõѧ˶Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-03-30 8/400 2026-03-31 08:53 by lbsjt
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û